comparemela.com

Latest Breaking News On - Tara biotherapeutics aktie - Page 1 : comparemela.com

Atara Biotherapeutics and Pierre Fabre Laboratories Announce Publication of Phase 3 ALLELE Tab-cel Data in The Lancet Oncology

01.02.2024 - Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, and Pierre . Seite 1

United statesPascal touchonAmerican society of hematologyAtara biotherapeutics incEuropean unionPierre fabre laboratoriesPierre fabreChief executive officerLancet oncologyAtara biotherapeutics chartTara biotherapeutics kursTara biotherapeutics aktie

Atara Biotherapeutics To Present Positive New Tab-cel Clinical Data During Oral Session at ESMO Immuno-Oncology Annual Congress 2023

30.11.2023 - Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today . Seite 1

Executive vice presidentMedical officerComplete responsePartial responseAtara biotherapeutics chartTara biotherapeutics kursTara biotherapeutics aktie

vimarsana © 2020. All Rights Reserved.